Publications by authors named "Warren Mason"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,509

Total Likes

603

Extended Reach

8,000,823

Social Features

213
V
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial.
Timothy F Cloughesy, Martin J van den Bent, Mehdi Touat, Deborah T Blumenthal, Katherine B Peters, Warren P Mason

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.
Howard Colman, Giuseppe Lombardi, Eric T Wong, Tobias Walbert, Marica Eoli, Warren Mason

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma.
Emilie Le Rhun, Debaleena Sain, Sara C Erridge, David A Reardon, Giuseppe Minniti, Warren Mason

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedure.
Jonas Willmann, Joost J C Verhoeff, Orit Kaidar-Person, André Abrunhosa-Branquinho, Enrico Clementel, Warren P Mason

Radiother Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Warren P Mason

Nat Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma.
James R Whittle, Maria Vieito, Kristoffer Rohrberg, Maria E Rodriguez-Ruiz, Eduardo Castanon, Warren Mason

Neurooncol Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in IDH-mutant glioma management: IDH inhibitors, clinical implications of INDIGO trial, and future perspectives.
Christianne V Mojica, Katrina Mari E Gutierrez, Warren P Mason

Future Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis.
Julie Bennett, Adrian B Levine, Liana Nobre, Logine Negm, Jiil Chung, Warren P Mason

Nat Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors.
Abdulrahman Alghabban, Lucy Corke, Hans Katzberg, Vera Bril, Carolina Barnett-Tapia, Warren Mason

JTO Clin Res Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating Life With High-Grade Glioma: Experiences and Needs of Adolescents and Young Adults.
Kaviya Devaraja, Maureen Daniels, Derek S Tsang, Kim Edelstein, Julie Bennett, Warren Mason

Cancer Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study.
Warren P Mason, Rebecca A Harrison, Sarah Lapointe, Mary Jane Lim-Fat, Mary V MacNeil

Curr Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary adolescent and young adult neuro-oncology clinic: Clinical cases, practice challenges, and future perspectives.
Christianne V Mojica, Thiago Pimentel Muniz, Xin Wang, Stephanie Baker, Kim Edelstein, Warren P Mason

Neurooncol Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal leptomeningeal vascular anomalies on brain MRI: A mimic of leptomeningeal metastatic disease.
Alexandre Boutet, Mikail Malik, Andrew Z Yang, Jurgen Germann, Samuel S Haile, Warren P Mason

Neurooncol Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial.
Annika Malmström, Felix B Oppong, Christopher J O Callaghan, Wolfgang Wick, Normand Laperriere, Warren Mason

Neurooncol Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.
Patrick Roth, Thierry Gorlia, Jaap C Reijneveld, Filip de Vos, Ahmed Idbaih, Warren Mason

Neuro Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of Etoposide for Recurrent Glioma.
Matthijs van der Meulen, Manik Chahal, Warren P Mason

Can J Neurol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma.
Cha Len Lee, Grainne M O'Kane, Warren P Mason, Wen-Jiang Zhang, Pavlina Spiliopoulou

Mol Cancer Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.
Christopher Hahn, Adrian Budhram, Katayoun Alikhani, Nasser AlOhaly, Grayson Beecher, Warren Mason

Can J Neurol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma.
Matthijs van der Meulen, Ronald C Ramos, Mathew R Voisin, Vikas Patil, Qingxia Wei, Warren P Mason

Neurooncol Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update.
Roa Alsajjan, Warren P Mason

Curr Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic Targets.
Thiago P Muniz, Warren P Mason

CNS Drugs· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Warren P Mason

Nat Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of 20 years of adult medulloblastoma treatment: Chemotherapy prescription trends and survival.
Marissa Sherwood, Seth Climans, Ronald Ramos, Normand J Laperriere, Andrew F Gao, Warren P Mason

Neurooncol Pract· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma.
Angela Sekely, Lori J Bernstein, Kristin L Campbell, Warren P Mason, Normand Laperriere

Neurooncol Pract· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis